Tumores Gastrintestinais
Revisão | Colangiocarcinoma.
12 Set, 2021 | 21:34hCholangiocarcinoma – Nature Reviews Disease Primers (gratuito por tempo limitado)
Infográfico: Cholangiocarcinoma
Comentário no Twitter
Get Primed on #Cholangiocarcinoma with our NEW PrimeView! FREE to download this week! https://t.co/xw8yl29QI4 pic.twitter.com/JKtL6NqnlS
— Nature Reviews Disease Primers (@DiseasePrimers) September 9, 2021
Revisão | Câncer pancreático.
12 Set, 2021 | 20:03hPancreatic Cancer: A Review – JAMA (gratuito por tempo limitado)
Uso de antibióticos está associado a risco aumentado de câncer colorretal subsequente.
8 Set, 2021 | 15:02hComentários:
Antibiotics linked to increased risk of colon cancer – Umea University
Study links antibiotics use and increased subsequent risk of colorectal cancer – MedicalResearch.com
Diretrizes de prática clínica da ESMO adaptada para a Pan-Ásia para diagnóstico, tratamento e seguimento de pacientes com câncer de cólon localizado.
26 Ago, 2021 | 12:14hEstudo de coorte | Associação da remoção incompleta de pólipo em colonoscopia com risco de câncer colorretal no seguimento.
17 Ago, 2021 | 11:17hEstudo original: Recurrence of Colorectal Neoplastic Polyps After Incomplete Resection – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Incidência e mortalidade globais do câncer gástrico, 1980-2018.
13 Ago, 2021 | 11:55hGlobal Incidence and Mortality of Gastric Cancer, 1980-2018 – JAMA Network Open
Lesões císticas pancreáticas: achados de imagem de RM e tratamento.
11 Ago, 2021 | 10:28hCystic pancreatic lesions: MR imaging findings and management – Insights into Imaging
Conteúdos relacionados:
Recommendations for the management of incidental pancreatic findings in adults.
Pancreatic cystic neoplasms: a review of current recommendations for surveillance and management
Management of Pancreatic Cystic Lesions
Consensus Recommendations: Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions
Review: Pancreatic Cystic Lesions
Guidelines on pancreatic cystic neoplasms
Estudo randomizado | Eficácia da quimioterapia concomitante com S-1 vs. radioterapia isolada para pacientes idosos com câncer esofágico.
9 Ago, 2021 | 11:14hEfficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial – JAMA Oncology (gratuito por tempo limitado)
Editorial: Primary Chemoradiotherapy for Older Patients With Esophageal Cancer (gratuito por tempo limitado)
Comentário: Concurrent CRT Effective for Esophageal Cancer in Older Patients — Overall survival at 2 years significantly better versus radiotherapy alone – MedPage Today (necessário cadastro gratuito)
Comentário no Twitter
Randomized phase 3 trial of radiation with or w/o S-1 chemo in 298 older pts (median age 77) with esophageal cancer reveals concurrent chemoradiation led to significantly improved progression-free & overall survival https://t.co/wx5FG5VDUH #GICSM pic.twitter.com/SFddL53lCi
— JAMA Oncology (@JAMAOnc) August 6, 2021
Recomendações de consenso internacional sobre as principais medidas de desfecho para preservação de órgão após (químio)radioterapia em paciente com câncer retal.
5 Ago, 2021 | 11:34hEstudo randomizado | Nivolumabe com quimioterapia vs. quimioterapia isolada para adenocarcinomas esofágico, de junção gastresofágica e gástrico avançados.
3 Ago, 2021 | 11:09hFirst-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)
Comentário no Twitter (fio – clique para sair mais)
#Nivolumab plus chemotherapy shows superior OS, PFS benefit, and acceptable safety profile—compared to chemotherapy alone—in previously untreated advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma.
🔗 https://t.co/0u9R5ZIwd2, by @YJanjigianMD et al.
— The Lancet (@TheLancet) July 8, 2021